IL10 and Crohn disease: L. lactis bacteria were the first microorganisms used in clinical studies in humans, where patients with moderate and advanced Crohn’s disease after treatment with genetically modified L. lactis producing human IL-10 showed in majority an improvement in clinical parameters assessed by Crohn’s Disease Activity Index (CDAI) [38].